{
    "score": [
        0.2727272727272727
    ],
    "extracted": [
        0
    ],
    "abstract": [
        "here 's why you should invest in masimo right now ."
    ],
    "id": "433434.train",
    "article": [
        "shares of masimo corporation masi have rallied 27.3 % over a year , ahead of the s&p 500 index 's 18.6 % gain and the broader industry 's 20.5 % rise . the stock has a market cap of $ 4.46 billion . masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies , medical devices , and a wide array of sensors . the company 's five-year historical growth rate is also favorable at 14.4 % compared with 2.8 % of the s&p 500 index and 9 % of the broader industry . ",
        "its current-year earnings growth is projected at 43.4 % , higher than 16.9 % for the broader industry and 23 % for the s&p 500 index . with solid prospects , this zacks rank # 2 stock is an attractive pick at present . let 's find out whether the recent positive trends can help sustain this stock in the long run . the company has witnessed a positive estimate revision for the current year . the stock has seen the zacks consensus estimate being revised upward with five analysts moving north in the past 60 days , with no movement in the opposite direction . ",
        "earnings per share estimates were increased around 5.4 % to $ 2.95 . the company also has a stellar average return of 13.2 % over the last four quarters . the market is upbeat about masimo 's solid guidance , where the company expects fiscal 2017 revenues of approximately $ 774 million , up from the previously issued guidance of $ 769.0 million . total fiscal 2017 product revenues are projected at approximately $ 741 million , up from the prior view of $ 736 million . fiscal 2017 earnings per share are expected at around $ 2.95 , up from $ 2.80 . ",
        "meanwhile , masimo won the fda approval and announced the u. s. release of the full family of nomoline capnography sampling lines . of the latest developments , artemis hospital , a multi-specialty hospital in the delhi-ncr region of india is adopting masimo patient safetynet across all hospital care areas . patient safetynet allows clinicians at a central station to review the patient data being continuously relayed from bedside monitoring devices . this marks the company 's globally extended foothold . also , masimo announced the full-market release of ras-45 , a single use adhesive respiration sensor for rainbow acoustic monitoring of respiration rate . ",
        "this launch is expected to strengthen the company 's position in the growing global respiratory care market . key picksother top-ranked medical stocks include bruker corporation brkr , align technology , inc. . algn and chemed corporation che . while bruker and align technology sport a zacks rank # 1 , chemed carries a zacks rank of 2 . you can see the complete list of today 's zacks # 1 rank stocks here . bruker has a long-term expected earnings growth rate of 9.9 % . the stock has rallied roughly 57.1 % over a year . align technology has a long-term expected earnings growth rate of 28.9 % . ",
        "the stock has skyrocketed 126.1 % in a year . chemed has a long-term expected earnings growth rate of 10 % . the stock has soared 50.9 % in a year . zacks editor-in-chief goes `` all in '' on this stockfull disclosure , kevin matras now has more of his own money in one particular stock than in any other . he believes in its short-term profit potential and also in its prospects to more than double by 2019 . today he reveals and explains his surprising move in a new special report . download it free > > want the latest recommendations from zacks investment research ? ",
        "today , you can download 7 best stocks for the next 30 days . click to get this free reportbruker corporation : free stock analysis reportmasimo corporation : free stock analysis reportchemed corp. . : free stock analysis reportalign technology , inc. . : free stock analysis reportto read this article on zacks . com click here .   "
    ]
}